ONCOassist® | The go-to oncology app

🚀 ONCOassist voted #1! 🏆

We’re excited to share that ONCOassist has been rated the top app for cancer care in a recent evaluation using the Mobile App Rating Scale (MARS). With a score of 4.25, we led the way in engagement, functionality, and trusted information.

Thank you to the TRANSiTION team for recognizing our commitment to empowering oncology professionals globally.

Together, we’re transforming cancer care!

#OncoAlert #CancerCare #Innovation @oncoalert @EuropeanCancer

🎥 New on #OncologyBytes from #IUCS2026

Dr Farid Rajaee Rizi (@faridrajaee1) explores AI for surgical planning in radical prostatectomy.

🤖 EPE prediction: AUC 0.89
🔬 Intraoperative tissue classification: AUC 0.93 (internal)
⚠️ Validation remains a challenge.

Share this with a colleague and watch the full video on the ONCOassist app.

#ProstateCancer #AI #Oncoassist @urologysummit
@gbanna74 @nataliagandur

🎧 Oncology Spotlight – New Episode

AI won’t replace oncologists but it could change how they learn, stay current & work.

On Oncology Spotlight, Dr Roupen Odabashian (@RoupenMD) & Dr Daniel Barnett, founders of Meducation.ai (@MeDucationai) discuss AI, oncology education, hallucinations, human oversight & the future of cancer care.

🎙️ Watch the full episode on the ONCOassist app.

#AIinOncology #Oncology #meducationai #medtwitter #onctwitter

🎥 New on #OncologyBytes from #IUCS2026
Dr Sian Cooper explores prostate swelling during MR-guided adaptive radiotherapy.

📊 10,297 fractions analysed
➡️ SBRT showed faster swelling onset
➡️ Smaller baseline prostates had greater swelling risk

Share this with a colleague and watch the full video on the ONCOassist app.

#ProstateCancer #SBRT #Radiotherapy #Oncoassist @urologysummit @gbanna74 @nataliagandur @ManiamAkash

Take the ONCO-IQ Quiz Cup Encore quiz here: bit.ly/ENCO_ONCO_IQ_X

What 6-year absolute overall survival gain did adjuvant ribociclib show in NATALEE for HR+ early breast cancer?